Pharma serialization solutions provider Systech International is adding two professionals to its Board of Directors, John Bailye and Michael Fawkes. “We are delighted to welcome new members to our Board, John Bailye and Michael Fawkes, who bring a vast amount of industry experience and business acumen upon which Systech will draw as we continue to grow,” said Robert DeJean, President and CEO, Systech International, in a press release.
During its public board meeting on December 13, the California State Board of Pharmacy discussed written and oral comments provided in response to the first proposed regulations needed to implement the state’s electronic drug pedigree provisions.
In July, dozens of people were charged in New York City for diverting and trafficking prescription drugs for treating HIV that were paid for by Medicaid, in some cases twice. Diverters reportedly purchased prescribed drugs from Medicaid beneficiaries, removed patient labeling from bottles, and added counterfeit labels as needed to redistribute the drugs back in the supply chain. According to a press release issued by the U.S.
Inference refers to inferring “the contents of a case, pallet, or other aggregate of individual units, packages, or containers of dangerous drugs, from a unique identifier associated with the case, pallet, or other aggregate, without opening each case, pallet, or other aggregate or otherwise individually validating each unit,” according to the California State Board of Pharmacy (CA BoP).
Speakers at GS1 Connect in June shared several business reasons to standardize product identification. Health systems representatives spoke of efficiencies that standardized identification could bring in product and patient identification and tracking as well as improvements in billing, ordering, and inventory. Many spoke of the need for standards, such as the GS1 family of standards.
At ACHEMA 2012, Seidenader Maschinenbau GmbH will showcase a new inspection station that measures and evaluates stress birefringence in containers, which can help identify specific prestages of crack formation, the company reports. The station will be integrated into a Seidenader MS inspection machine for vials with a throughput of up to 24,000 containers/hour. Another system will be shown for inspecting up to 36,000 syringes per hour for particles or cosmetic defects. Feeding and orientation of the syringes is provided by a Seidenader SyWalker.
GS1 US has appointed Siobhan O’Bara as vice president, healthcare. O’Bara is now responsible for setting strategy and ensuring achievement of operating results for GS1 Healthcare US, including supporting GS1 Standards implementation initiatives
across the U.S. healthcare industry, the standards organization reported in a press release.